First, just as SARS-CoV-2 utilizes the complementarity between its spike protein and ACE-2 to infect specific cell types, so the bacteria associated with COVID-19 utilize the complementarity between their extracellular protein antigens, such as enolase and pyruvate kinase, and extracellular matrix proteins, such as laminins, collagens, and fibronectins [143,144], on human tissues. This evidence concerns the gene FN1 and COVID-19.